Gujarat Kidney And Super Speciality Limited (GKSL) — Board Meeting(2 announcements)

· NSE 🟡 Notable Neutral
1 Board Meeting 🟡 Notable Neutral 📄 PDF
📢 Key Event
Board approved appointment of Company Secretary, subsidiary incorporation, and shareholder resolutions for fund utilization and financial revisions.
🔄 What Changed
Appointment of new Company Secretary; incorporation of healthcare subsidiary in Bharuch; shareholder approval of interim fund use for healthcare expansion aligned with IPO; voluntary financial statement revision; appointment of secretarial auditors.
🔮 What's Next
Subsidiary incorporation to be completed on or before end of first half of FY 2026-27.
💡 Investor Takeaway
The subsidiary expansion targets healthcare growth in Bharuch, potentially boosting future revenue but may dilute value through new capital allocation.

Gujarat Kidney and Super Speciality Limited announced the outcome of its April 27, 2026 board meeting, appointing Ms. Vishakha Mahesh Phadke as Company Secretary and Compliance Officer effective that date, incorporating a wholly owned subsidiary in Bharuch to expand healthcare services, and approving shareholder resolutions for interim fund utilization toward healthcare expansion aligned with its IPO objectives, voluntary financial statement revisions, and appointment of secretarial auditors. The board noted no promoter or director interests in these matters, and the subsidiary will be capitalized with Rs 1 lakh initially, with full cash subscription planned. The meeting ran from 5:00 PM to 6:15 PM.

2 Board Meeting 🟡 Notable Neutral 📄 PDF
📢 Key Event
Board approves appointment of Company Secretary and subsidiary incorporation
🔄 What Changed
New subsidiary incorporation approved; interim fund utilization authorized
🔮 What's Next
Subsidiary incorporation to be completed by end of first half of FY 2026-27
💡 Investor Takeaway
Subsidiary expansion targets Bharuch healthcare growth with no promoter conflicts

Gujarat Kidney and Super Speciality Limited announced the outcome of its April 27, 2026 board meeting, appointing Ms. Vishakha Mahesh Phadke as Company Secretary and Compliance Officer effective the same date, and approving the incorporation of a wholly owned subsidiary in Bharuch, Gujarat to expand healthcare services. Shareholders also approved interim fund utilization for healthcare expansion, voluntary financial statement revisions, and appointment of a new secretarial auditor via postal ballot. The board noted no promoter or director interests in these matters.

About Gujarat Kidney And Super Speciality Limited (GKSL)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹1,081.89 Cr

View full GKSL stock details →

📡 Get AI alerts when GKSL files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GKSL — Free

📊 More GKSL filings

See all GKSL filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when GKSL files new disclosures

Track GKSL filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GKSL — Free

Free account · 2 AI queries/day